longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Tela Bio

TELA

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -1.42, below the reasonable range, cheaper than 90.04% of the time in the past 1 years, and the industry ranks 27/45, the industry Median -0.42.

-1.42xP/E
$1.30Stock price
$-0.92Earnings per share
-1.42xP/E
Stock price$1.30Earnings per share$-0.92

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-1.00x
Typical range
-1.29x–-0.82x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
015304560

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BLCOUSBausch + Lomb
-35.09x94.03%$6.00B
MMEDUSMiniMed
-18.92x146.72%$5.94B
NEOGUSNeogen
-375.66x316.68%$2.97B
ESTAUSEstablishment Labs
-51.91x30.16%$2.02B
XRAYUSDentsply Sirona
-3.45x113.34%$1.88B
KIDSUSOrthopediatrics
-14.69x27.74%$583.55M
CERSUSCerus
-76.06x56.25%$515.90M
SMTIUSSanara Medtech
-10.09x104.59%$323.14M
OSURUSOraSure Tech
-5.18x29.79%$254.49M
RXSTUSRxSight
-4.55x0.68%$213.79M
SKYAUSSkyAI
-0.19x--$77.41M
ZTEKFUSZENTEK LTD
-7.86x--$59.02M
TELAUSTela Bio
-1.42x17.67%$58.36M
XTNTUSXtant Med
-4.25x477.77%$47.28M
RMTIUSRockwell Medical
-6.69x32.67%$35.07M
NSPRUSInspireMD
-0.66x--$34.87M
RVPUSRetractable Tech
-5.90x--$21.25M
CUPRUSCuprina
-3.67x--$13.24M
LUCYUSInnovative Eyewear
-1.06x--$8.18M
AIDXUS20/20 Biolabs
-0.84x44.74%$6.00M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.